Skip to Content

MEBEVERINE TABLETS BP 135MG

Active substance: MEBEVERINE HYDROCHLORIDE

View full screen / Print PDF » Download PDF ⇩
Transcript
REG0066404

Version 1.7

Approved

WHAT MEBEVERINE IS AND
WHAT IT IS USED FOR

BEFORE YOU TAKE
MEBEVERINE

Pharma code 416

(Main)

Page 1 of 3

Taking other medicines
Please tell your doctor or pharmacist if
you are taking or have recently taken
any other medicines, including

Take special care with Mebeverine
Talk to your doctor before you start to
take this medicine if you:
• suffer from acute porphyria (an
enzyme deficiency).

Do NOT take Mebeverine if you:
• are allergic (hypersensitive) to
mebeverine hydrochloride or any of
the other ingredients of this medicine
• have paralytic ileus (paralysis of part
of the gut).

2

Mebeverine is used to treat:
• spasms in the gut
• irritable bowel syndrome and other
similar conditions.

Mebeverine is an anti-spasm drug.

1

IN THIS LEAFLET:
1. What Mebeverine is and what it is
used for
2. Before you take Mebeverine
3. How to take Mebeverine
4. Possible side effects
5. How to store Mebeverine
6. Further information

Read all of this leaflet carefully before
you start taking this medicine.
• Keep this leaflet. You may need to
read it again.
• If you have any further questions, ask
your doctor or pharmacist.
• This medicine has been prescribed for
you. Do not pass it on to others. It
may harm them, even if their
symptoms are the same as yours.
• If you get any side effects, talk to your
doctor or pharmacist. This includes
any possible side effects not listed in
this leaflet. See section 4.

PACKAGE LEAFLET: INFORMATION
FOR THE USER

MEBEVERINE 135 mg
TABLETS BP

PAGE 1: FRONT FACE (INSIDE OF REEL)

231-30-63134-ZA LEA MEBEVERINE 135 mg TAB REEL

HOW TO TAKE MEBEVERINE

If you take more Mebeverine than you
should
If you (or someone else) swallow a lot of
the tablets all together, or if you think a
child has swallowed any of the tablets,
contact your nearest hospital casualty
department or your doctor immediately.
Please take this leaflet, any remaining

Children and adolescents under 18 years
of age:
Mebeverine is not recommended.

After several weeks, once the desired
effect has been achieved, your doctor
may gradually reduce your dose.

Adults (including the elderly):
1 tablet three times a day preferably
about 20 minutes before eating.

Always take Mebeverine exactly as your
doctor has told you. You should check
with your doctor or pharmacist if you are
not sure. The tablets should be
swallowed preferably with a drink of
water. The usual dose is:

3

You should also note that Mebeverine
contains propylene glycol (E1520), which
may cause alcohol-like symptoms and the
preservative methyl
parahydroxybenzoate (E218), which may
cause delayed allergic reactions, mainly
affecting the skin.

Important information about some of
the ingredients of Mebeverine
Patients who are intolerant to lactose
and sucrose should note that
Mebeverine Tablets contain a small
amount of lactose and sucrose. If you
have been told by your doctor that you
have an intolerance to some sugars,
contact your doctor before taking this
medicinal product.

Driving and using machines
Mebeverine is not known to affect your
ability to drive or operate machinery.

Pregnancy and breast-feeding
If you are pregnant, planning to become
pregnant or breast-feeding, ask your
doctor for advice before taking this
medicine.

medicines obtained without a
prescription.

TEVA UK Ref:

Top of page cut-off to middle of registration mark: 21mm. Registration Pitch: 210mm -0.45mm (Sheet depth / cut-off length: 210mm)

1
21 May 2015

PAGE 2: REAR FACE (OUTSIDE OF REEL)

POSSIBLE SIDE EFFECTS

HOW TO STORE MEBEVERINE
Keep out of the reach and sight of
children. Mebeverine Tablets should be
o
stored in a dry place at or below 20 C
protected from light in the package or
container supplied. Do not transfer them
to another container. Do not use
Mebeverine after the expiry date that is

5

Reporting of side effects
If you get any side effects, talk to your
doctor or pharmacist. This includes any
possible side effects not listed in this
leaflet. You can also report side effects
directly via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard
By reporting side effects you can help
provide more information on the safety
of this medicine.

This is a very serious but rare side
effect. You may need urgent medical
attention or hospitalisation.

If the following happens, stop taking the
tablets and tell your doctor immediately
or go to the casualty department at your
nearest hospital:
• an allergic reaction (swelling of the
lips, face or neck leading to severe
difficulty in breathing; skin rash or
hives).

Like all medicines, Mebeverine can
cause side effects, although not
everybody gets them.

4

If you have any further questions on the
use of this product, ask your doctor or
pharmacist.

If you stop taking Mebeverine
Do not stop taking your medicine
without talking to your doctor first even
if you feel better.

If you forget to take Mebeverine
If you forget to take a tablet, take one as
soon as you remember, unless it is
nearly time to take the next one. Do not
take a double dose to make up for a
forgotten dose. Take the remaining
doses at the correct time.

FURTHER INFORMATION

PL 00289/0095

TEVA UK Limited

This leaflet was last revised:
May 2015

63134-ZA

Marketing Authorisation Holder and
Manufacturer
Marketing Authorisation holder: TEVA
UK Limited, Eastbourne, BN22 9AG.

What Mebeverine Tablets look like and
contents of the pack:
• Mebeverine Tablets are white or
almost white, biconvex, sugar coated
tablets. They are plain on one side and
printed 135/4301 on the reverse.
• Mebeverine Tablets are available in
pack sizes of 7, 10, 14, 21, 28, 30, 56,
60, 84, 90, 100, 110, 112, 120, 150, 160
and 168 tablets.
Not all pack sizes may be marketed.

What Mebeverine Tablets contain:
• The active ingredient is mebeverine
hydrochloride.
• The other ingredients are lactose
monohydrate, potato starch, sodium
starch glycolate, povidone K30,
purified talc (E553), magnesium
stearate (E572). The tablet coating
contains: sucrose, purified talc (E553),
calcium carbonate, macro glyceryl
ricinoleate, titanium dioxide (E171),
acacia, magnesium stearate, methyl
parahydroxybenzoate (E218) and
white beeswax (E901). The printing ink
contains: shellac, black iron oxide
(E172) and propylene glycol (E1520).

6

Medicines should not be disposed of via
wastewater or household waste. Ask
your pharmacist how to dispose of
medicines no longer required. These
measures will help to protect the
environment.

tablets and the container with you to the stated on the outer packaging. The
expiry date refers to the last day of that
hospital or doctor so that they know
month.
which tablets were consumed.

Version:

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide